INIS
antibodies
12%
cell cultures
12%
communities
10%
comparative evaluations
23%
concentration
11%
coronaviruses
100%
data
12%
detection
11%
diseases
33%
doses
17%
dynamics
30%
education
11%
epidemiology
11%
genes
11%
heat
11%
host
24%
humans
17%
immunity
11%
inactivation
11%
infants
11%
lungs
14%
macrophages
13%
medical centers
23%
mice
11%
panels
14%
pathogens
19%
patients
19%
pcr
14%
polymerase chain reaction
11%
populations
23%
protection
11%
proteins
20%
public health
14%
resolution
12%
rna
25%
splicing
11%
strains
11%
surveillance
22%
testing
30%
tissues
16%
tools
29%
transcription
20%
transmission
61%
travel
11%
universities
48%
urine
11%
vaccines
20%
values
13%
viruses
64%
workers
17%
Keyphrases
5′-end
6%
Anterior Nares
11%
Anti-B Cell Therapy
5%
BinaxNOW
11%
Biosafety Level 4
6%
Close Contact
11%
COVID-19
11%
Delta Variant
5%
Fetal Lung
5%
Gene Signature
11%
Heat Inactivation
11%
Human Fetus
5%
Human Immune System
5%
Human Lung Tissue
11%
Humanized Mice
11%
In-person Learning
5%
India
5%
Infant Urine
11%
Lung Tissue
5%
MAb114
11%
Macrophages
11%
Major League Soccer
11%
Mica
8%
Nipah Virus
11%
Pfizer-BioNTech
11%
Protein Splicing
11%
Public Health Mandates
11%
RadA
9%
Robust Transmission
5%
Sample Quality
11%
Sarbecoviruses
11%
SARS-CoV-2 Infection
11%
Single-cell RNA Sequencing (scRNA-seq)
11%
Soccer Clubs
11%
Time to Culture Conversion
7%
Tissue Protection
11%
University Environment
5%
University Population
11%
Unstable Housing
11%
Unvaccinated
5%
Urban Universities
11%
Viral
11%
Viral Host
11%
Virus Inactivation
6%
VP30
6%
Xenograft
5%
ZsGreen
11%
Medicine and Dentistry
Cohort Analysis
14%
Contact Examination
14%
Coronavirinae
5%
COVID-19
19%
Culture Conversion
11%
Diagnosis
13%
Genomic Epidemiology
11%
Infection
21%
Infection Control
5%
Macrophage
11%
Omicron Coronavirus Variant
11%
Public Health
13%
Reinfection
11%
Reverse Transcription Polymerase Chain Reaction
10%
Sensitivity and Specificity
7%
Severe Acute Respiratory Syndrome Coronavirus 2
94%
Symptom
11%
Whole Genome Sequencing
6%